<div class='field field--name-field-medicine-uses field--type-string-long field--label-above' style='-webkit-text-stroke-width:0px;color:rgb(34, 35, 48);font-family:Ginter, Inter, &quot;Helvetica Neue&quot;, BlinkMacSystemFont, -apple-system, &quot;Segoe UI&quot;, Roboto, Oxygen-Sans, Ubuntu, Cantarell, sans-serif;font-size:15px;font-style:normal;font-variant-caps:normal;font-variant-ligatures:normal;font-weight:400;letter-spacing:normal;orphans:2;text-align:start;text-decoration-color:initial;text-decoration-style:initial;text-decoration-thickness:initial;text-indent:0px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;'>Endogest AQ25 Injection 1.119 ml is used in the maintenance of early pregnancy and treatment of dysfunctional uterine bleeding, threatened abortion, and amenorrhea. The detailed uses of Endogest AQ25 Injection 1.119 ml are as follows: &lt;br/&gt;<ul><li>Menstrual Cycle Regulation: Endogest AQ25 Injection 1.119 ml helps to regulate irregular menstrual cycles, treating conditions like amenorrhea by stabilizing hormonal imbalances and promoting a regular menstrual cycle.&lt;br/&gt;</li><li>Treatment of Abnormal Uterine Bleeding: By controlling hormone levels and possibly lowering excessive bleeding during menstruation, Endogest AQ25 Injection 1.119 ml can help manage abnormal uterine bleeding.&lt;br/&gt;</li><li><span style='-webkit-text-stroke-width:0px;background-color:rgb(255, 255, 255);color:rgb(34, 35, 48);display:inline !important;float:none;font-family:Ginter, Inter, &quot;Helvetica Neue&quot;, BlinkMacSystemFont, -apple-system, &quot;Segoe UI&quot;, Roboto, Oxygen-Sans, Ubuntu, Cantarell, sans-serif;font-size:15px;font-style:normal;font-variant-caps:normal;font-variant-ligatures:normal;font-weight:400;letter-spacing:normal;orphans:2;text-align:start;text-decoration-color:initial;text-decoration-style:initial;text-decoration-thickness:initial;text-indent:0px;text-transform:none;white-space:normal;widows:2;word-spacing:0px;'>Luteal Phase Support: Endogest AQ25 Injection 1.119 ml is prescribed to support the luteal phase during assisted reproductive technologies like in vitro fertilization (IVF), increasing the chances of pregnancy.&lt;br/&gt; &nbsp;</li></ul></div>

Medicinal Benefits:

Endogest AQ25 Injection 1.119 ml is used to maintain early pregnancy in cases of documented history of repeated miscarriages due to luteal phase defect
This medicine is also used as an adjunct to successful infertility treatment with techniques such as in vitro fertilisation (IVF) or gamete intra-fallopian transfer (GIFT) to facilitate uterine implantation of the fertilised ovum.
In cases of secondary amenorrhoea (paused or missed periods), it can also be used as a progesterone withdrawal test to assess oestrogen priming.
Furthermore, it can treat threatening abortions and dysfunctional uterine haemorrhages.

FAQs

What is the use of Endogest AQ25 Injection 1.119 ml?

Endogest AQ25 Injection 1.119 ml is used to treat various medical conditions, including early pregnancy maintenance, dysfunctional uterine bleeding, and threatened abortion. Besides this, it can also be used for the progesterone withdrawal test in the endocrinal evaluation of secondary amenorrhoea (paused or missed periods) to judge oestrogen priming.

How does Endogest AQ25 Injection 1.119 ml work?

Endogest AQ25 Injection 1.119 ml contains progesterone; it works by increasing levels of the hormone progesterone in your body.

Does Endogest AQ25 Injection 1.119 ml cause darkening of facial skin?

The most prevalent negative effect of using Endogest AQ25 Injection 1.119 ml is the darkening of the facial skin. Please report to the doctor immediately if you notice any significant or rapid changes.

Is it ideal to use Endogest AQ25 Injection 1.119 ml in patients with certain cancers such as breast or genital organs?

Using Endogest AQ25 Injection 1.119 ml is contraindicated in people with cancers such as breast or genital organs. So, inform your doctor if you have cancer in your breasts or genital organs.

What are the limitations to the use of Endogest AQ25 Injection 1.119 ml?

Endogest AQ25 Injection 1.119 ml is contraindicated in people allergic to progesterone or people diagnosed with porphyria (a disorder in the formation of red blood pigment), cancers in breasts or genital organs, or a blocked blood vessel, vaginal infections, and/or people with missed abortion.

Does Endogest AQ25 Injection 1.119 ml cause hair loss?

Hair loss is the most prevalent negative effect of utilizing Endogest AQ25 Injection 1.119 ml. If you notice any significant or abnormal hair loss, please immediately report it to the doctor.